HealthyDirect · Growth
UTI Fixed Term Income Fund Series XXXVI - I (1574 Days)
UTI Mutual FundClose Ended Schemes(Income/Debt Oriented Schemes - Fixed Term Plan3.5 years
- NAV
- 13.0649
- 15 Sept 2026
- 1Y
- +5.9%
- Trailing CAGR
- AUM
- ₹47.98 Cr
- 30 Jun 2026
- Volatility
- Low
- 1.2% annualized
NAV
Path not in current snapshots
n/a
Returns
Trailing CAGR and simulated monthly SIP XIRR from daily NAV. Category comparison uses the median of comparable share classes in the peer set.
Trailing CAGR
Point-to-point, calendar-day annualized
- 1Y+5.9%
- 3Y+7.6%
- 5Yn/a
- 10Yn/a
- SI+7.8%
SIP XIRR
Equal monthly instalments to latest NAV
- 1Y+5.7%
- 3Y+7.1%
- 5Yn/a
- 10Yn/a
- Since inception
- +7.8%
- Calendar-day CAGR
- Excess 1Y
- n/a
- Category median, same plan and option
- 3Y win rate
- n/a
- Windows beating the median
- 3Y percentile
- n/a
- Vs comparable share classes
- Worst rolling 3Y
- +7.3%
- 130 daily-ending windows
- Median rolling 3Y
- +7.6%
- Calendar-day CAGR
- Positive rolling 5Y
- n/a
- 0 daily-ending windows
- SIP 3Y XIRR
- +7.1%
- Simulated monthly SIP
Drawdown
Peak to trough from a running NAV high. Move across the path to read a date.
Drawdown
Path not in current snapshots
n/a
- Average recovery
- 3 days
- 130 recovered episodes
- Longest recovery
- 22 days
- Trough to prior peak
- Current spell
- 0 days
- Days below latest peak
- Time below peak
- +43%
- NAV observations
27 Sept 2023 – 31 Oct 2023
Trough 9 Oct 2023 · recovered in 22 days
-0.6%
27 Jun 2023 – 13 Jul 2023
Trough 7 Jul 2023 · recovered in 6 days
-0.4%
4 Aug 2025 – 1 Sept 2025
Trough 12 Aug 2025 · recovered in 20 days
-0.3%
6 Jun 2025 – 24 Jun 2025
Trough 13 Jun 2025 · recovered in 11 days
-0.3%
Dimensions
0–100 reads of named metrics. The mean is unweighted and only uses dimensions with data.
Returns
42
Vs category
n/a
Consistency
n/a
Risk-adjusted
100
Drawdown
99
Mean
80
Decision
Quantitative read of the live evidence. An explanation can only restate what is already here.
As of 15 Sept 2026
Healthy
Engine status
Healthy
Doing its job
Why this status
- No material deterioration, cost shock, or persistent category underperformance in the current evidence set.
Supporting reads
- Risk-adjusted return sits above the documented risk-free proxy.
- Peak-to-trough drawdown has stayed shallower than 15%.